Understanding Predictors of Fatigue Over Time in Persons With Inflammatory Bowel Disease : The Importance of Depressive and Anxiety Symptoms
Copyright © 2024 by The American College of Gastroenterology..
INTRODUCTION: Fatigue is a complex and frequent symptom in persons with inflammatory bowel disease (IBD), with detrimental impact. We aimed to determine predictors of fatigue over time.
METHODS: Two hundred forty-seven adults with IBD participated in a prospective study conducted in Manitoba, Canada, providing data at baseline and annually for 3 years. Participants reported fatigue impact (Daily Fatigue Impact Scale [DFIS]), depression and anxiety symptoms (Hospital Anxiety and Depression Scale [HADS]), and pain (Pain Effects Scale [PES]). Physician-diagnosed comorbidities, IBD characteristics, and physical and cognitive functioning were also assessed. We tested factors associated with fatigue using multivariable generalized linear models that estimated within-person and between-person effects.
RESULTS: Most participants were women (63.2%), White (85.4%), and had Crohn's disease (62%). At baseline, 27.9% reported moderate-severe fatigue impact, 16.7% had clinically elevated anxiety (HADS-A ≥11), and 6.5% had clinically elevated depression (HADS-D ≥11). Overall fatigue burden was stable over time, although approximately half the participants showed improved or worsening fatigue impact between annual visits during the study. On multivariable analysis, participants with a one-point higher HADS-D score had, on average, a 0.63-point higher DFIS score, whereas participants with a one-point higher PES score had a 0.78-point higher DFIS score. Within individuals, a one-point increase in HADS-D scores was associated with 0.61-point higher DFIS scores, in HADS-A scores with 0.23-point higher DFIS scores, and in PES scores with 0.38-point higher DFIS scores. No other variables predicted fatigue.
DISCUSSION: Anxiety, depression, and pain predicted fatigue impact over time in IBD, suggesting that targeting psychological factors and pain for intervention may lessen fatigue burden.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
The American journal of gastroenterology - (2024) vom: 26. Jan. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Bernstein, Charles N [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 25.01.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.14309/ajg.0000000000002630 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM365791466 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM365791466 | ||
003 | DE-627 | ||
005 | 20240125232007.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.14309/ajg.0000000000002630 |2 doi | |
028 | 5 | 2 | |a pubmed24n1270.xml |
035 | |a (DE-627)NLM365791466 | ||
035 | |a (NLM)38088416 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Bernstein, Charles N |e verfasserin |4 aut | |
245 | 1 | 0 | |a Understanding Predictors of Fatigue Over Time in Persons With Inflammatory Bowel Disease |b The Importance of Depressive and Anxiety Symptoms |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 25.01.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright © 2024 by The American College of Gastroenterology. | ||
520 | |a INTRODUCTION: Fatigue is a complex and frequent symptom in persons with inflammatory bowel disease (IBD), with detrimental impact. We aimed to determine predictors of fatigue over time | ||
520 | |a METHODS: Two hundred forty-seven adults with IBD participated in a prospective study conducted in Manitoba, Canada, providing data at baseline and annually for 3 years. Participants reported fatigue impact (Daily Fatigue Impact Scale [DFIS]), depression and anxiety symptoms (Hospital Anxiety and Depression Scale [HADS]), and pain (Pain Effects Scale [PES]). Physician-diagnosed comorbidities, IBD characteristics, and physical and cognitive functioning were also assessed. We tested factors associated with fatigue using multivariable generalized linear models that estimated within-person and between-person effects | ||
520 | |a RESULTS: Most participants were women (63.2%), White (85.4%), and had Crohn's disease (62%). At baseline, 27.9% reported moderate-severe fatigue impact, 16.7% had clinically elevated anxiety (HADS-A ≥11), and 6.5% had clinically elevated depression (HADS-D ≥11). Overall fatigue burden was stable over time, although approximately half the participants showed improved or worsening fatigue impact between annual visits during the study. On multivariable analysis, participants with a one-point higher HADS-D score had, on average, a 0.63-point higher DFIS score, whereas participants with a one-point higher PES score had a 0.78-point higher DFIS score. Within individuals, a one-point increase in HADS-D scores was associated with 0.61-point higher DFIS scores, in HADS-A scores with 0.23-point higher DFIS scores, and in PES scores with 0.38-point higher DFIS scores. No other variables predicted fatigue | ||
520 | |a DISCUSSION: Anxiety, depression, and pain predicted fatigue impact over time in IBD, suggesting that targeting psychological factors and pain for intervention may lessen fatigue burden | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Fisk, John D |e verfasserin |4 aut | |
700 | 1 | |a Dolovich, Casandra |e verfasserin |4 aut | |
700 | 1 | |a Hitchon, Carol A |e verfasserin |4 aut | |
700 | 1 | |a Graff, Lesley A |e verfasserin |4 aut | |
700 | 1 | |a El-Gabalawy, Renée |e verfasserin |4 aut | |
700 | 1 | |a Lix, Lisa M |e verfasserin |4 aut | |
700 | 1 | |a Bolton, James M |e verfasserin |4 aut | |
700 | 1 | |a Patten, Scott B |e verfasserin |4 aut | |
700 | 1 | |a Marrie, Ruth Ann |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The American journal of gastroenterology |d 1953 |g (2024) vom: 26. Jan. |w (DE-627)NLM000025445 |x 1572-0241 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:26 |g month:01 |
856 | 4 | 0 | |u http://dx.doi.org/10.14309/ajg.0000000000002630 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 26 |c 01 |